Skip to main content
ACHIEVE LIFE SCIENCES, INC. logo

ACHIEVE LIFE SCIENCES, INC. — Investor Relations & Filings

Ticker · ACHV ISIN · US0044685008 LEI · 549300V82ZKZDTAU0A46 US Manufacturing
Open in API
Filings indexed 1,013 across all filing types
Latest filing 2009-12-21 Capital/Financing Update
Country US United States of America
Listing US ACHV

About ACHIEVE LIFE SCIENCES, INC.

https://achievelifesciences.com/

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 19, 2009, reporting a material definitive agreement between OncoGenex Pharmaceuticals and Teva Pharmaceutical Industries. It details the terms of a collaboration and license agreement, including financial terms, development plans, and amendments to related license agreements. The document includes no financial statements or quarterly results but focuses on a significant financing and collaboration transaction. This fits the definition of a Capital/Financing Update (CAP) as it reports on company fundraising, financing activities, and capital structure changes. The document length is substantial and contains detailed agreement terms, not just an announcement or summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is CAP with high confidence.
2009-12-21 English
Regulatory Filings 2009
Regulatory Filings
2009-12-10 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically reports the resignation of a director and the appointment of new directors to committees, as well as the fixing of the board size. This matches the description of announcements related to changes in the company's board of directors or senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and contains no financial data or other report types, confirming it is not an annual or interim report or other filings. Confidence is high due to clear and explicit content matching the MANG category.
2009-11-24 English
10-Q
Interim / Quarterly Report 9M 2009
2009-11-05 English
FORM 8-K
Earnings Release Classification · 90% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company issued a press release announcing its financial results for the quarter ended September 30, 2009. The press release is attached as an exhibit and is incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. Given the short length (2674 characters) and the nature of the content (announcement of financial results via press release), this document is best classified as an Earnings Release (ER) announcement within an 8-K filing. The document is not the full earnings release text but the 8-K filing referencing it. However, since the press release is attached as an exhibit and the main purpose is to announce quarterly financial results, the classification aligns with Earnings Release (ER). Confidence is high due to explicit mention of quarterly financial results and press release attachment.
2009-11-05 English
FORM 8-K
Regulatory Filings
2009-10-06 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.